Capillary Glycerolemia Evolution During Physical Exercise
LSEEGLYCEROL
1 other identifier
interventional
12
1 country
1
Brief Summary
Maximum fatty acid oxidation is known to occur at exercise intensities between 45 and 65% VO2max and in the fasting state. However, the optimal level may depend on various unknown factors. Glycerolemia is a good marker of the fatty acid metabolism but its evolution remains poorly described, maybe due to the difficulty of the measure. A new device allows an easy measurement of glycerolemia during exercise and could enable personalization strategies to optimize exercise efficacy. In this study, the investigators plan to test three different exercise types and three different fasting conditions with three replicates each to evaluate the variability of glycerolemia and its evolution during exercise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 1, 2019
CompletedFirst Posted
Study publicly available on registry
September 10, 2019
CompletedStudy Start
First participant enrolled
October 23, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 11, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 11, 2020
CompletedFebruary 25, 2021
November 1, 2020
11 months
August 1, 2019
February 24, 2021
Conditions
Outcome Measures
Primary Outcomes (5)
concentration of glycerol in capillary blood
The primary endpoint is the time series of measurements of capillary glycerol concentration using the DietSee device (LSEE, Ajaccio, France)
at the beginning of exercise
concentration of glycerol in capillary blood
The primary endpoint is the time series of measurements of capillary glycerol concentration using the DietSee device (LSEE, Ajaccio, France)
20 minutes after the beginning of exercise
concentration of glycerol in capillary blood
The primary endpoint is the time series of measurements of capillary glycerol concentration using the DietSee device (LSEE, Ajaccio, France)
30 minutes after the beginning of exercise
concentration of glycerol in capillary blood
The primary endpoint is the time series of measurements of capillary glycerol concentration using the DietSee device (LSEE, Ajaccio, France)
45 minutes after the beginning of exercise
concentration of glycerol in capillary blood
The primary endpoint is the time series of measurements of capillary glycerol concentration using the DietSee device (LSEE, Ajaccio, France)
60 minutes after the beginning of exercise
Secondary Outcomes (2)
1. Maximum concentration of glycerol in capillary blood
from the beginning of the exercise and during one hour
2. Glycerol concentration in peripheral venous blood,
30 minutes after the beginning of bodybuilding exercise (i.e. at the end of the exercice)
Study Arms (1)
Single Arm
EXPERIMENTALEvery patient will undergo every combination of physical exercise/meal type (3x3 combinations), one following the other. Each combination is replicated three times.
Interventions
standardized physical activity (moderate intensity) lasting 30 minutes and having a warm-up portion of 5 minutes
standardized physical activity (high intensity) lasting 30 minutes and having a warm-up portion of 5 minutes
standardized physical activity (bodybuilding) lasting 30 minutes and having a warm-up portion of 5 minutes
\- Hyperlipidic meal Energy supply: 800 kcal Distribution of macronutrients: proteins: 15% +/- 5; carbohydrates: 40% +/- 5; lipids: 45 +/- 5 Choice of foods determined with the dietician taking into account the patient's tastes and products available on the market The same meal will be taken before the 3 sessions concerned.
\- Hyperglucidic meal Energy supply: 800 kcal Macronutrient distribution: protein 15% +/- 5; carbohydrates 60% +/- 5; lipids 25 +/- 2 Choice of foods determined with the dietician taking into account the patient's tastes and products available on the market. The same meal will be taken before the 3 sessions concerned.
Eligibility Criteria
You may qualify if:
- Major patients followed in Diabetology-Nutrition Day Hospital of Bichat-Claude Bernard Hospital as part of the ETAPES program
- overweight or obese patient: body mass index BMI\> 25 kg / m²
- Volunteer to participate in and follow a proposed physical activity program as part of regular follow-up
- Volunteer to participate in the research, comfortable with the use of the device of auto measurement of capillary glycerolemia
You may not qualify if:
- Pregnancy in progress or breastfeeding
- Patient under guardianship or curatorship
- Patient participating in another interventional research protocol
- No affiliation to the social security scheme or French Universal Health Cover (CMU)
- Absence of informed consent, written and signed
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Bichat Claude-Bernard
Paris, 75018, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Boris HANSEL, MD PHD
Assistance Publique - Hôpitaux de Paris
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 1, 2019
First Posted
September 10, 2019
Study Start
October 23, 2019
Primary Completion
September 11, 2020
Study Completion
September 11, 2020
Last Updated
February 25, 2021
Record last verified: 2020-11
Data Sharing
- IPD Sharing
- Will not share